Abbott 4 jun 2026 Abbott shares rise as investors refocus on diabetes tech and cancer-diagnostics momentum - Quiver Quantitative
Abbott 2 jun 2026 ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence - Medical Device Network
Abbott 1 jun 2026 Advances in Molecular Residual Disease Detection and Risk Stratification: Insights from Abbott Cancer Diagnostics - Onco'Zine
Abbott 28 may 2026 Abbott obtains CE mark for duo of glucose-ketone monitors - Medical Device Network
Abbott 27 may 2026 How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026 - Yahoo! Finance Canada
Abbott 26 may 2026 Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 - PR Newswire
Abbott 23 may 2026 Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables - simplywall.st
Abbott 21 may 2026 Abbott Laboratories stock (US0028241000): diabetes business and latest earnings in focus - AD HOC NEWS
Abbott 19 may 2026 Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
Abbott 13 may 2026 Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold? - TradingView
Abbott 11 may 2026 Lateral Flow Assay Component Market Is Going to Boom | Abbott Laboratories, BD - openPR.com
Abbott 8 may 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - The Globe and Mail
Abbott 8 may 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance UK
Abbott 8 may 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance Singapore
Abbott 28 abr 2026 Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com